OrthoPediatrics’ Management and Board of Directors take it’s environmental, social and governance (“ESG”) responsibility very seriously. We feel these areas are core to our business philosophy and ultimately create increased shareholder value. Our internal ESG team is led by our COO & CFO and reports directly to our Governance and Nominating Committee.
OrthoPediatrics cares about our environmental impact while working in a highly controlled industry and is certified according to ISO 14001.
Production of OrthoPediatrics products takes place through highly regulated contract manufacturer and supplier qualifications and quality control is a high priority area.
Suppliers are carefully selected, and high demands are placed on their compliance with applicable regulations.
We undergo an annual certification that there are no Conflict Minerals including used in the production of or in our products.
A sub-committee focuses on reducing the impact we make on the environment through energy-efficient resourcing and recycling.
OrthoPediatrics is a company founded on the Cause of improving the lives of pediatric patients. We feel a responsibility to improve healthcare for children all over the world whose lives have been impacted by musculoskeletal issues.
Since starting OrthoPediatrics we estimate that we have impacted the lives of over 200,000 children as well as their parents and loved ones.
We believe that a strong culture is key to our success, and we focus on continuous improvements in an engaging and healthy work environment.
OrthoPediatrics employees complete an annual assessment survey, and we are proud of our record as a five-time winner of the “Best Places to Work in Indiana”.
The company and our associates regularly participate in various philanthropic pursuits in our local communities as well as partnering with organizations around the world. In 2020 we were named as “Corporate Partner of the Year” from the World Pediatric Project – with whom we work to provide access to medical care to children in developing countries.
The Company has implemented a Global Ethics & Compliance Program that requires annual training. The Program includes the Company’s Code of Ethics & Business Conduct (“Code of Conduct”) Policy and Anti-Corruption Policy, and a series of other policies, procedures and trainings to provide relevant information for specific responsibilities.
The Code of Conduct policy describes the basis for how employees and partners should act dealing with customers, hospitals, surgeons, partners as well as fellow employees.
The Compliance whistleblowing hotline and email enable employees and external partners to report any issues, including violations of the Company’s policies and procedures, violations of U.S. or international laws, and or concerns about the Company’s accounting, internal controls or auditing related matters, suspected bribery, corruption, or violations of the Code of Conduct. The hotline and email are administered by an external third party and communicated directly to the Chairman of the Audit Committee.
The Board of Directors understands the value of diversity and has been discussing the need to increase the Board diversity for some time. The Board recently hired an external global recruiting firm to aid in our goal of adding two additional diverse candidates over the next 12-18 months.
The Company and the Board does not directly utilize paid lobbyists nor does it permit political donations to obtain or retain business or to gain an improper business advantage for the Company.
The Company has a separate Executive Chairman of the Board and CEO